查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
流式細胞儀市場：依技術、產品和應用進行預測 - 附執行顧問指南（2024-2028）
市場調查報告書
商品編碼
1472609

流式細胞儀市場：依技術、產品和應用進行預測 - 附執行顧問指南（2024-2028）

Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 401 Pages | 商品交期: 最快1-2個工作天內

價格

流式細胞儀是研究細胞的分析方法的支柱，隨著新興的免疫腫瘤學和液體活檢市場在癌症治療競賽中產生前所未有的投資，其成長目前正在加速。

此外，基於基因組的新知識正在促進新一代單細胞科學探索。這個市場還在不斷成長。製藥業的支柱正成為生物技術的核心。

該報告審視了全球流式細胞儀市場，並提供了市場概述、技術、產品和應用的趨勢，以及參與該市場的公司概況。

目錄

第一章 市場引導

第二章介紹和市場定義

  • 什麼是流式細胞儀？
  • 市場定義
  • 調查方法
  • 美國醫療市場前景與藥物研究成本

第 3 章流式細胞儀 - 技術指南

  • 流式細胞儀
  • 硬件
  • 數據分析
  • 細胞分選
  • 標籤
  • 珠陣列
  • 阻抗流式細胞儀
  • 流式細胞儀的應用

第四章 行業概況

  • 市場進入組織
    • 學術研究所
    • CRO組織
    • 基因組設備供應商
    • 細胞分離與觀察供應商
    • 細胞系和試劑供應商
    • 製藥公司
    • 審計機構
    • 認證機構

第五章 市場趨勢

  • 增長動力
  • 生長抑制因素
  • 技術開發

第 6 章流式細胞儀的最新進展

第七章 主要公司簡介

  • Agilent/Dako
  • Amphasys
  • Apogee Flow Systems
  • Applied Cytometry
  • Astrolabe Diagnostics
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BennuBio
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Cytek Biosciences
  • Cytognos
  • Cytonome
  • De Novo Software
  • Gemini Bio
  • Kinetic River
  • Logos Biosystems
  • Luminex Corp（DiaSorin）
  • Miltenyi Biotec
  • Molecular Devices
  • Nanion
  • NanoCellect Biotechnology
  • Omiq
  • On-Chip Biotechnologies
  • Partek
  • Sartorius
  • SBT Instruments
  • Singleron Biotechnologies
  • Sony Biotechnology
  • Standard BioTools
  • Stratedigm
  • Sysmex
  • Sysmex Partec
  • Tecan
  • Tercen Data
  • Thermo Fisher Scientific Inc.
  • TissueGnostics
  • Union Biometrica
  • Verity Software House
  • Yokogawa Fluid Imaging Technologies

第八章 全球流式細胞儀市場概況

  • 依國家/地區劃分的世界市場概覽
  • 依產品劃分的全球市場規模概覽
  • 依應用劃分的全球市場規模概覽
  • 依技術劃分的全球市場規模概覽

第九章全球流式細胞儀市場（依產品）

  • 試劑
  • 設備
  • 服務
  • 軟件

第10章全球流式細胞儀市場（依應用）

  • 研究
  • 臨床
  • 行業
  • 其他

第十一章全球流式細胞儀市場（依技術）

  • 凝膠
  • 珠子

第十二章附錄

OVERVIEW:

Flow Cytometry is a mainstay of analytical methods to study cells, but growth is now accelerating as new immuno-oncology and liquid biopsy markets create unprecedented investment in the race to cure cancer. Research vs. Clinical, Bead vs. Gel, its all here in this comprehensive report.

On top of this new genome based knowledge is fostering a new generation of scientific exploration of single cells. This market just keeps on growing with no end in sight. The workhorse of the pharmaceutical industry is becoming a central player in biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Situation Analysis
  • 1.2. Guide for Executives and Marketing Staff
  • 1.3. Guide for Investment Analysts and Management Consultants

2. Introduction and Market Definition

  • 2.1. What is Flow Cytometry?
    • 2.1.1. Cell Sorting
    • 2.1.2. Academic Use
  • 2.2. Market Definition
    • 2.2.1. Market Size.
    • 2.2.2. Currency.
    • 2.2.3. Years.
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. U.S. Medical Market and Pharmceutical Research Spending-Perspective
    • 2.4.1. U.S. Expenditures for Pharmaceutical Research

3. Flow Cytometry-Guide to Technology

  • 3.1. Flow Cytometers
  • 3.2. Hardware
    • 3.2.1. Fluidics
      • 3.2.1.1. Hydrodynamic Focusing
      • 3.2.1.2. Acoustic Focusing
    • 3.2.2. Optics and electronics
      • 3.2.2.1. Optical filters
      • 3.2.2.2. Prisms, gratings, and spectral flow cytometry
      • 3.2.2.3. Imaging flow cytometry
  • 3.3. Data analysis
    • 3.3.1. Compensation
    • 3.3.2. Gating
    • 3.3.3. Computational analysis
    • 3.3.4. FMO controls
  • 3.4. Cell Sorting
  • 3.5. Labels
    • 3.5.1. Fluorescent labels
    • 3.5.2. Quantum dots
    • 3.5.3. Isotope labeling
  • 3.6. Bead Array
  • 3.7. Impedance flow cytometry
  • 3.8. Flow Cytometry Applications
  • 3.9. Cell Viability Assays
  • 3.10. Cell Proliferation Assays
  • 3.11. Cytotoxicity Assays
  • 3.12. Cell Senescence Assays
  • 3.13. Apoptosis
  • 3.14. Autophagy
  • 3.15. Necrosis
  • 3.16. Oxidative Stress
  • 3.17. Signalling Pathways, GPCR
  • 3.18. Immune Regulation & Inhibition
  • 3.19. Reporter Gene Technology

4. Industry Overview

  • 4.1. Players in a Dynamic Market
    • 4.1.1. Academic Research Lab
    • 4.1.2. Contract Research Organization
    • 4.1.3. Genomic Instrumentation Supplier
    • 4.1.4. Cell Separation and Viewing Supplier
    • 4.1.5. Cell Line and Reagent Supplier
    • 4.1.6. Pharmaceutical Company
    • 4.1.7. Audit Body
    • 4.1.8. Certification Body

5. Market Trends

  • 5.1. Factors Driving Growth
    • 5.1.1. The Move to Cell Based Analytics
    • 5.1.2. Immuno-oncology
    • 5.1.3. Genomic Blizzard
    • 5.1.4. Technology Convergence
  • 5.2. Factors Limiting Growth
    • 5.2.1. Genomic Technology Competition
    • 5.2.2. Instrument Integration
    • 5.2.3. Maturity
  • 5.3. Technology Development
    • 5.3.1. Software
    • 5.3.2. Instrument Size
    • 5.3.3. Larger Panels
    • 5.3.4. The Next Five Years

6. Flow Cytometry Recent Developments

  • 6.1. Recent Developments-Importance and How to Use This Section
    • 6.1.1. Importance of These Developments
    • 6.1.2. How to Use This Section
  • 6.2. Virax Biolabs Partners for Long COVID Study
  • 6.3. Agilent Aims for Early-Stage CDx Development Deals
  • 6.4. Navigate BioPharma Services To Collaborate with BD
  • 6.5. bioAffinity Technologies Acquires Assets of Precision Pathology Services
  • 6.6. Bio-Rad enhances flow cytometry capabilities
  • 6.7. BD Launches New Robotic System
  • 6.8. Hybrid Flow Cytometer
  • 6.9. BD and A*STAR collaborate
  • 6.10. Cytek Biosciences to Acquire Flow Cytometry Business
  • 6.11. METAFORA Launches a Digital Cytometry Analysis Platform
  • 6.12. In Vitro Potency Assays Utilize Flow Cytometry
  • 6.13. Celerion to Offer Molecular and Cell Biology Testing
  • 6.14. Beckman Coulter launches Cytobank v10 Platform
  • 6.15. NASA Deploys Flow Cytometer in Space
  • 6.16. BD, Labcorp to Develop Flow Cytometry-Based Companion Diagnostics
  • 6.17. Slingshot Biosciences Partners With Cambridge Bioscience to Distribute Synthetic Cells
  • 6.18. Canopy Bio Targeting High-Throughput Spatial Proteomics
  • 6.19. Becton Dickinson Advancing Rapid Image-Based Cell Sorting Tech
  • 6.20. Insightful Science Acquires Data Science Company Omiq
  • 6.21. Single-Cell Startup Nodexus Raises $30M
  • 6.22. Bio-Rad Laboratories StarBright UltraViolet 400 Dye for Flow Cytometry
  • 6.23. Cytek Biosciences Acquires Cell Analysis Business of Tonbo Biosciences
  • 6.24. Becton Dickinson FACSymphony A5 SE Cell Analyzer
  • 6.25. Biotium ExoBrite EV Membrane Staining Kits
  • 6.26. Cytek Biosciences Prices $200M Initial Public Offering
  • 6.27. Invivoscribe 12-Color Flow Cytometry Service
  • 6.28. Beckman Coulter launches CytoFLEX SRT benchtop cell sorter
  • 6.29. Thermo Fisher Acquires Cell Sorting Technology From Propel Labs
  • 6.30. Thermo Fisher Acquires Programmable Dye Platform Pioneer Phitonex
  • 6.31. NGS Bests Flow Cytometry for MRD-Based Prediction
  • 6.32. Bio-Rad Launches New StarBright Dyes
  • 6.33. Cytek Biosciences Closes $120M Financing Round
  • 6.34. Cellular Analytics Detects Early Mesothelioma Using Liquid Biopsy
  • 6.35. Cytek Biosciences Gets CE Mark for Flow Cytometer
  • 6.36. Aigenpulse launches suite to automate flow cytometry
  • 6.37. Sysmex Partec to Distribute De Novo Flow Cytometry Software

7. Profiles of Key Flow Cytometry Companies

  • 7.1. Agilent/Dako
  • 7.2. Amphasys
  • 7.3. Apogee Flow Systems
  • 7.4. Applied Cytometry
  • 7.5. Astrolabe Diagnostics
  • 7.6. Beckman Coulter Diagnostics
  • 7.7. Becton, Dickinson and Company
  • 7.8. BennuBio
  • 7.9. bioMerieux Diagnostics
  • 7.10. Bio-Rad Laboratories, Inc.
  • 7.11. Cytek Biosciences
  • 7.12. Cytognos
  • 7.13. Cytonome
  • 7.14. De Novo Software
  • 7.15. Gemini Bio
  • 7.16. Kinetic River
  • 7.17. Logos Biosystems
  • 7.18. Luminex Corp (DiaSorin)
  • 7.19. Miltenyi Biotec
  • 7.20. Molecular Devices
  • 7.21. Nanion
  • 7.22. NanoCellect Biotechnology
  • 7.23. Omiq
  • 7.24. On-Chip Biotechnologies
  • 7.25. Partek
  • 7.26. Sartorius
  • 7.27. SBT Instruments
  • 7.28. Singleron Biotechnologies
  • 7.29. Sony Biotechnology
  • 7.30. Standard BioTools
  • 7.31. Stratedigm
  • 7.32. Sysmex
  • 7.33. Sysmex Partec
  • 7.34. Tecan
  • 7.35. Tercen Data
  • 7.36. Thermo Fisher Scientific Inc.
  • 7.37. TissueGnostics
  • 7.38. Union Biometrica
  • 7.39. Verity Software House
  • 7.40. Yokogawa Fluid Imaging Technologies

8. Flow Cytometry Global Market Overview

  • 8.1. Global Market Overview by Country
    • 8.1.1. Table-Global Market by Country
    • 8.1.2. Chart-Global Market by Country
  • 8.2. Global Market Size by Product-Overview
    • 8.2.1. Table-Global Market by Product
    • 8.2.2. Chart-Global Market by Product-Base/Final Year Comparison
    • 8.2.3. Chart-Global Market by Product-Base Year
    • 8.2.4. Chart-Global Market by Product-Final Year
    • 8.2.5. Chart-Global Market by Product-Share by Year
    • 8.2.6. Chart-Global Market by Product-Segment Growth
  • 8.3. Global Market Size by Application-Overview
    • 8.3.1. Table-Global Market by Application
    • 8.3.2. Chart-Global Market by Application-Base/Final Year Comparison
    • 8.3.3. Chart-Global Market by Application-Base Year
    • 8.3.4. Chart-Global Market by Application-Final Year
    • 8.3.5. Chart-Global Market by Application-Share by Year
    • 8.3.6. Chart-Global Market by Application-Segment Growth
  • 8.4. Global Market Size by Technology-Overview
    • 8.4.1. Table-Global Market by Technology
    • 8.4.2. Chart-Global Market by Technology-Base/Final Year Comparison
    • 8.4.3. Chart-Global Market by Technology-Base Year
    • 8.4.4. Chart-Global Market by Technology-Final Year
    • 8.4.5. Chart-Global Market by Technology-Share by Year
    • 8.4.6. Chart-Global Market by Technology-Segment Growth

9. Global Market by Product

  • 9.1. Reagent Market
    • 9.1.1. Table-Reagent Market by Country
    • 9.1.2. Chart-Reagent Market Segment Growth
  • 9.2. Instrument Market
    • 9.2.1. Table-Instrument Market by Country
    • 9.2.2. Chart-Instrument Market Segment Growth
  • 9.3. Services Market
    • 9.3.1. Table-Services Market by Country
    • 9.3.2. Chart-Services Market Segment Growth
  • 9.4. Software Market
    • 9.4.1. Table-Software Market by Country
    • 9.4.2. Chart-Software Market Segment Growth

10. Global Market by Application

  • 10.1. Research Market
    • 10.1.1. Table-Research Market by Country
    • 10.1.2. Chart-Research Market Segment Growth
  • 10.2. Clinical Market
    • 10.2.1. Table-Clinical Market by Country
    • 10.2.2. Chart-Clinical Market Segment Growth
  • 10.3. Industrial Market
    • 10.3.1. Table-Industrial Market by Country
    • 10.3.2. Chart-Industrial Market Segment Growth
  • 10.4. Other Application Market
    • 10.4.1. Table-Other Application Market by Country
    • 10.4.2. Chart-Other Application Market Segment Growth

11. Global Market by Technology

  • 11.1. Gel Market
    • 11.1.1. Table-Gel Market by Country
    • 11.1.2. Chart-Gel Market Segment Growth
  • 11.2. Bead Market
    • 11.2.1. Table-Bead Market by Country
    • 11.2.2. Chart-Bead Market Segment Growth

12. Appendices

  • 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2. FDA Cancer Drug Approvals by Year
  • 12.3. Clinical Trials Started 2010 to 2016
  • 12.4. Share of Pharma R&D by Country

Table of Tables

  • Table 1: Some Characterics Measured by Flow Cytometry
  • Table 2: Some Common Viability Assays
  • Table 3: Oxidative Stress Related Diseases
  • Table 4: Important Signalling Pathways
  • Table 5: Market Players by Type
  • Table 6: Four Factors Driving Growth
  • Table 7: Three Factors Limiting Growth
  • Table 8: Global Market by Country/Region
  • Table 9: Global Market by Product
  • Table 10: Global Market by Application
  • Table 11: Global Market by Technology
  • Table 12: Reagent Market by Country
  • Table 13: Instrument Market by Country
  • Table 14: Services Market by Country
  • Table 15: Software Market by Country
  • Table 16: Research Market by Country
  • Table 17: Clinical Market by Country
  • Table 18: Industrial Market by Country
  • Table 19: Other Application Market by Country
  • Table 20: Gel Market by Country
  • Table 21: Bead Market by Country
  • Table 22: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Pharmaceutical Research Expenditures ($Billion)
  • Figure 2: Oxidative Stress and Free Radical Toxicity
  • Figure 3: FDA Cancer Drug Approvals
  • Figure 4: Immunotherapy vs Traditional
  • Figure 5: Growth rates of Flow Cytometry by Product Class
  • Figure 6: Market Size by Country
  • Figure 7: Global Market by Product-Base vs. Final Year
  • Figure 8: Product Market Base Year
  • Figure 9: Product Market Final Year
  • Figure 10: Product Share by Year
  • Figure 11: Product Segment Growth
  • Figure 12: Global Market by Application-Base vs. Final Year
  • Figure 13: Application Market Base Year
  • Figure 14: Application Market Final Year
  • Figure 15: Application Share by Year
  • Figure 16: Application Segment Growth
  • Figure 17: Global Market by Technology-Base vs. Final Year
  • Figure 18: Technology Market Base Year
  • Figure 19: Technology Market Final Year
  • Figure 20: Technology Share by Year
  • Figure 21: Technology Segment Growth
  • Figure 22: Chart-Reagent Market Growth
  • Figure 23: Chart Instrument Market Growth
  • Figure 24: Chart-Services Market Growth
  • Figure 25: Chart-Software Market Growth
  • Figure 26: Chart-Research Market Growth
  • Figure 27: Chart Clinical Market Growth
  • Figure 28: Chart-Industrial Market Growth
  • Figure 29: Chart-Other Application Market Growth
  • Figure 30: Chart-Gel Market Growth
  • Figure 31: Chart Bead Market Growth
  • Figure 32: FDA Cancer Drug Approvals by Year
  • Figure 33: Clinical Trials for Immunotherapy by Year
  • Figure 34: Share of Pharma R&D by Country